Adibkia, Khosro
Research Center for Pharmaceutical Nanotechnology,
Iran, Islamic Republic of
2025 Rank: 136,124
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 967 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 136,124 | 139,357 |
| Total Cites | 979 | 1,056 |
| H-index | 13 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 50 | 51 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 487 | 507 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 921 | 973 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.09 |
| Self-Citation Percentage |
7.29%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 798 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118,680 | 120,821 |
| Total Cites | 954 | 1,038 |
| H-index | 14 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 45 | 52 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 490 | 523 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 891 | 940 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
8.09%
|
|
Adibkia, Khosro
Research Center for Pharmaceutical Nanotechnology,
Iran, Islamic Republic of
2023 Rank: 131,928
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 927 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131,928 | 144,794 |
| Total Cites | 901 | 987 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 48 | 50 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 487 | 509 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 830 | 892 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
8.71%
|
|
Adibkia, Khosro
Research Center for Pharmaceutical Nanotechnology,
Iran, Islamic Republic of
2022 Rank: 166,852
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1,256 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 166,852 | 176,958 |
| Total Cites | 742 | 837 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 29 | 32 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 377 | 396 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 700 | 760 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.10 |
| Self-Citation Percentage |
11.35%
|
|
Adibkia, Khosro
Research Center for Pharmaceutical Nanotechnology,
Iran, Islamic Republic of
2021 Rank: 173,086
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1,306 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 173,086 | 176,450 |
| Total Cites | 1,047 | 1,161 |
| H-index | 13 | 15 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 54 | 54 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 564 | 588 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 980 | 1,056 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
9.82%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Chemical Physics
Rank in SubField 1: 1,327 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 188,078 | 176,486 |
| Total Cites | 711 | 818 |
| H-index | 10 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 40 | 47 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 419 | 485 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 675 | 716 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.14 |
| Self-Citation Percentage |
13.08%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.